Abstract
Many conflicts in the literature about negative symptoms arise because different authors use different definitions of negative symptoms. If narrow definitions are used, it appears that drugs have little effect against negative symptoms, although those who use broader definitions tend to conclude that negative symptoms do respond to drugs. Another complication is that negative symptoms may be secondary to other causes, such as psychotic symptoms, the side effects of drugs, depression and understimulation as a result of hospitalisation. Attempting to measure drug effects on negative symptoms can be complicated by such factors as different co-medication in the test and control groups and different pharmacological profiles of test and standard drugs, in particular in terms of extrapyramidal side effects or antidepressant effects. Several approaches to dissecting the direct effect of drugs from their indirect effects on negative symptoms have included analyses of covariance, regression analyses and path analyses. Applying path analysis to the data from the North American clinical trial of risperidone suggests that a significant component of the advantageous effect of risperidone on negative symptoms, compared with haloperidol, is du...Continue Reading
References
Jan 1, 1989·Psychopharmacology·J AngstB Woggon
Jan 1, 1989·European Journal of Clinical Pharmacology·C H van der MeydenL C Pretorius
Jan 1, 1985·Schizophrenia Bulletin·W T CarpenterL D Alphs
Jan 1, 1985·Schizophrenia Bulletin·S C Goldberg
Jan 1, 1985·Schizophrenia Bulletin·T J Crow
May 1, 1988·The American Journal of Psychiatry·W T CarpenterA M Wagman
Jan 1, 1987·Neuropsychobiology·D P van KammenK L Malas
Jul 1, 1987·The American Journal of Psychiatry·R S KeefeK L Davis
Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Jan 1, 1985·Schizophrenia Bulletin·R D GibbonsJ O Cole
Aug 17, 1981·Biochimica Et Biophysica Acta·P A Andreasen
Jun 1, 1981·Journal of Endodontics·J O Andreasen
Jun 1, 1994·The American Journal of Psychiatry·S R Marder, R C Meibach
Jan 1, 1995·European Archives of Psychiatry and Clinical Neuroscience·H J MöllerG Chouinard
Feb 1, 1993·Journal of Clinical Psychopharmacology·G ChouinardW Arnott
Jun 1, 1994·Psychopharmacology·H J MöllerW W Fleischhacker
May 1, 1994·The British Journal of Psychiatry : the Journal of Mental Science·P BaileyJ P Macher
Mar 1, 1993·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·H J Möller
Citations
Jan 1, 1996·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·G BondolfiH Dufour
Jun 27, 2002·Schizophrenia Research·Hans-Jürgen MöllerAnton Strauss
Oct 5, 2001·European Psychiatry : the Journal of the Association of European Psychiatrists·S MoritzM Krausz
Feb 7, 1998·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·D J King
Oct 6, 2004·Expert Opinion on Pharmacotherapy·Henry Silver
Jul 17, 2007·European Archives of Psychiatry and Clinical Neuroscience·Michael RiedelHans-Jürgen Möller
Jul 3, 2008·European Archives of Psychiatry and Clinical Neuroscience·Hans-Jürgen Möller
Feb 28, 2003·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·H J Möller
Mar 23, 2001·Acta Psychiatrica Scandinavica. Supplementum·H J MöllerA Strauss
Oct 19, 2001·CNS Drug Reviews·H Silver